Trends in the approval of cancer therapies by the FDA in the twenty-first century
EC Scott, AC Baines, Y Gong, R Moore Jr… - Nature Reviews Drug …, 2023 - nature.com
The cancer treatment landscape has changed dramatically since the turn of the century,
resulting in substantial improvements in outcomes for patients. This Review summarizes …
resulting in substantial improvements in outcomes for patients. This Review summarizes …
Harnessing real-world evidence to advance cancer research
M Tang, SA Pearson, RJ Simes, BH Chua - Current Oncology, 2023 - mdpi.com
Randomized controlled trials (RCTs) form a cornerstone of oncology research by generating
evidence about the efficacy of therapies in selected patient populations. However, their …
evidence about the efficacy of therapies in selected patient populations. However, their …
COSMIC: a curated database of somatic variants and clinical data for cancer
Z Sondka, NB Dhir, D Carvalho-Silva… - Nucleic Acids …, 2024 - academic.oup.com
Abstract The Catalogue Of Somatic Mutations In Cancer (COSMIC), https://cancer. sanger.
ac. uk/cosmic, is an expert-curated knowledgebase providing data on somatic variants in …
ac. uk/cosmic, is an expert-curated knowledgebase providing data on somatic variants in …
[HTML][HTML] Genomic mapping of metastatic organotropism in lung adenocarcinoma
Summary We analyzed 2,532 lung adenocarcinomas (LUAD) to identify the
clinicopathological and genomic features associated with metastasis, metastatic burden …
clinicopathological and genomic features associated with metastasis, metastatic burden …
Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histologic transformation
Small cell lung cancer (SCLC) is a recalcitrant neuroendocrine carcinoma with dismal
survival outcomes. A major barrier in the field has been the relative paucity of human tumors …
survival outcomes. A major barrier in the field has been the relative paucity of human tumors …
Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma
D Mandelker, A Marra, B Zheng-Lin… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To determine the genetic predisposition underlying pancreatic acinar cell
carcinoma (PACC) and characterize its genomic features. METHODS Both somatic and …
carcinoma (PACC) and characterize its genomic features. METHODS Both somatic and …
Addressing the challenge of biomedical data inequality: An artificial intelligence perspective
Artificial intelligence (AI) and other data-driven technologies hold great promise to transform
healthcare and confer the predictive power essential to precision medicine. However, the …
healthcare and confer the predictive power essential to precision medicine. However, the …
Racial/ethnic and sex differences in somatic cancer gene mutations among patients with early-onset colorectal cancer
AN Holowatyj, W Wen, T Gibbs, HM Seagle, SR Keller… - Cancer discovery, 2023 - AACR
Molecular features underlying colorectal cancer disparities remain uncharacterized. Here,
we investigated somatic mutation patterns by race/ethnicity and sex among 5,856 non …
we investigated somatic mutation patterns by race/ethnicity and sex among 5,856 non …
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Background Homologous recombination repair mutation (HRRm) status may guide risk-
stratification and treatment decisions, including polyadenosine diphosphate–ribose …
stratification and treatment decisions, including polyadenosine diphosphate–ribose …
Molecular targeting of the BRAF proto-oncogene/mitogen-activated protein kinase (MAPK) pathway across cancers
KS Shan, TU Rehman, S Ivanov, G Domingo… - International Journal of …, 2024 - mdpi.com
The mitogen-activated protein kinase (MAPK) pathway is essential for cellular proliferation,
growth, and survival. Constitutive activation of this pathway by BRAF mutations can cause …
growth, and survival. Constitutive activation of this pathway by BRAF mutations can cause …